Elimination Half-Life May Explain the Relative Efficacy of Boceprevir and Telaprevir in the Treatment of Hepatitis C Virus Genotype 1

Author： Calcagno Andrea Boglione Lucio De Rosa Francesco Giuseppe Di Perri Giovanni Bonora Stefano

Publisher： Oxford University Press

ISSN： 1058-4838

Source： Clinical Infectious Diseases, Vol.56, Iss.11, 2013-06, pp. : 1677-1678

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Early Viral Response Predicts the Efficacy of Antiviral Triple Therapy with Simeprevir, Peg-Interferon and Ribavirin in Patients Infected with Hepatitis C Virus Genotype 1

Digestive Diseases, Vol. 33, Iss. 6, 2015-0 ,pp. : 708-714

Karger

Access to resources Recommend Favorite

Delayed Viral Clearance after 6-Week Treatment with Peginterferon Plus Ribavirin in a Patient with Chronic Hepatitis C Virus Genotype 1b

Case Reports in Gastroenterology, Vol. 10, Iss. 2, 2016-08 ,pp. : 417-422

Karger

Access to resources Recommend Favorite

Sustained Virological Response After 4 Weeks of Telaprevir, Peginterferon, and Ribavirin in an Asian Patient with Genotype 1 Chronic Hepatitis C and IL28B Genotype CC

By Brulotte Natalie Hahn Hejin Lee Maximilian

Digestive Diseases and Sciences, Vol. 59, Iss. 4, 2014-04 ,pp. : 737-739

Springer Publishing Company

Access to resources Recommend Favorite

Sustained Virological Response after 8-Week Treatment of Simeprevir with Peginterferon α-2a plus Ribavirin in a Japanese Female with Hepatitis C Virus Genotype 1b and IL28B Minor Genotype

Case Reports in Gastroenterology, Vol. 9, Iss. 2, 2015-07 ,pp. : 215-220

Karger

Access to resources Recommend Favorite

Safety, Tolerability, and Efficacy of Sofosbuvir Plus Ribavirin in Elderly Patients Infected with Hepatitis C Virus Genotype 2

Digestive Diseases, Vol. 34, Iss. 6, 2016-10 ,pp. : 632-639

Karger

Access to resources Recommend Favorite